Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., have described a next-generation vaccination technology ...

A new study in the journal Human Gene Therapy indicates that DNA impurities derived from plasmid and host cell DNA are ...

The first-of-its-kind in-depth bacterial evolutionary map could pave the way for the development of precision treatments for ...

The first-of-its-kind in-depth bacterial evolutionary map could pave the way for the development of precision treatments for certain antibiotic-resistant infections, such as urinary tract infections.

In this article, we discuss transformation, bacterial transformation in particular, and how scientists can utilize it to ...

Certain antibiotic-resistant infections could be treated with precision medicine in the future, thanks to a new resource mapping plasmids the ultimate vehicle of rapid bacterial evolution.

The combination of synchronous experimental process development and digital twin core model development is among the first of its kind.

The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory ...

PLC (AIM: 4BB) (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced that it has received ...

Despite these advancements, the process is often hindered by the numerous centrifugation steps required to pellet bacterial cells and isolate plasmid DNA. These steps slow down the process of ...